Notification under sub clause (c) of clause (ii) of the first proviso to clause (2) of section 17 of the Income tax Act,1961

## Report on Notification S.O. 3703(E) Regarding Income Tax Act, 1961 Section 17 **1. Executive Summary:** This report analyzes Notification S.O. 3703(E) issued by the Ministry of Finance, Department of Revenue, Central Board of Direct Taxes on August 5, 2022. This notification clarifies the conditions under which employees can claim income tax benefits related to COVID-19 medical treatment expenses. The notification specifies the documentation required from employees to substantiate such claims, effective retroactively from April 1, 2020, for the assessment year 2020-2021 and subsequent years. This report aims to provide a clear understanding of the notification's provisions and its implications for employers and employees. **2. Introduction:** This report provides an informative overview of Notification S.O. 3703(E), as published in The Gazette of India, focusing on its content and implications based solely on the text provided. The purpose is to elucidate the conditions and requirements outlined in the notification regarding income tax benefits related to COVID-19 treatment expenses. **3. Policy Overview:** This notification pertains to the Income-tax Act, 1961, specifically section 17, which defines "salary" for income tax purposes. The core objective of this notification, as inferred from the text, is to define the conditions under which medical expenses related to COVID-19 treatment can be excluded from an employee's taxable income under section 17. **4. Background and Rationale:** The notification is likely an amendment to existing regulations concerning medical benefits and income tax. The likely reason for this specific amendment is to provide clarity and specific guidance related to COVID-19, which would have been a novel situation requiring accommodation within existing tax laws. The amendment aims to address the tax implications of medical expenses incurred by employees and their families due to COVID-19. **5. Key Provisions / Changes:** This notification outlines the conditions for income tax benefits related to COVID-19 expenses. The amendment focuses specifically on the documentation required to support claims. The new rule/provision is: * To claim tax benefits for COVID-19 related medical expenses, employees *must* submit the following documents to their employer: * A COVID-19 positive report (employee or family member) or a medical report confirming COVID-19 diagnosis from a treating physician in a hospital or inpatient facility. * All necessary documents of medical diagnosis or treatment of the employee or his family member for COVID19 or illness related to COVID19 suffered within six months from the date of being determined as COVID19 positive. * A certification of all expenditures incurred on COVID-19 or related illness treatment for the employee or their family. The effect of this change is to establish a defined and auditable process for claiming tax exemptions related to COVID-19 medical expenses. **6. Target Audience and Stakeholders:** The target audience directly affected by these changes is: * Employees seeking income tax benefits for COVID-19 related medical expenses. * Employers responsible for processing employee income tax and ensuring compliance with tax regulations. **7. Implementation Aspects (Inferred):** Based on the text, the following can be inferred about implementation: * **Responsible agency/bodies:** The Central Board of Direct Taxes (CBDT) is responsible for issuing and overseeing the implementation of this notification. Employers are responsible for collecting the required documentation from employees and processing tax deductions accordingly. * **Timelines or procedures:** The notification is effective retroactively from April 1, 2020, and applies to the assessment year 2020-2021 and subsequent assessment years. Employees need to provide the specified documents to their employers to claim the benefits. **8. Expected Outcomes / Impact of Changes:** The likely intended outcome of these specific changes is to: * Provide a clear and standardized process for employees to claim tax benefits for COVID-19 related medical expenses. * Ensure accurate and transparent reporting of these expenses for tax purposes. * Reduce ambiguity and potential disputes regarding the eligibility of COVID-19 related expenses for tax exemptions. * Mitigate risks of fraudulent claims through stricter documentation requirements. **9. Conclusion:** Notification S.O. 3703(E) provides critical clarification and guidance on claiming income tax benefits for COVID-19 related medical expenses. By outlining the required documentation, the notification aims to streamline the process, ensure transparency, and provide clarity for both employees and employers. The notification's retroactive effect underscores its significance in addressing the unique financial burdens faced during the COVID-19 pandemic. Compliance with the outlined provisions is essential for both employees seeking tax relief and employers ensuring adherence to tax regulations.

Key Entities Referenced